Oregon's Healthcare Merger Oversight Law Fails to Block Deals Despite Five Years of Authority

Five years after Oregon enacted a pioneering law granting state regulators the power to block healthcare mergers and acquisitions, the state has not formally rejected a single transaction. The legislation, intended to prevent consolidation from driving up costs and reducing care access, has been criticized for its lack of enforcement. While it reportedly influenced the withdrawal of two high-profile deals, ProPublica analysis reveals that several approved transactions resulted in negative outcomes for patients. For instance, UnitedHealth Group’s acquisition of LHC Group led to the closure of a rural hospice, and Amazon’s purchase of One Medical resulted in clinic closures and decreased patient satisfaction. Additionally, a private equity firm closed a Salem hospice shortly after acquiring it, contrary to prior assurances. Critics, including former health policy board members, argue the oversight mechanism has performed poorly, failing to protect communities from service disruptions. The article highlights the case of Dana Gibbon, whose obstetric care was disrupted following a clinic acquisition, illustrating the real-world impact of these regulatory shortcomings on individual patients in Oregon.